Identification of Candidate Genes and Therapeutic Agents for Light Chain Amyloidosis Based on Bioinformatics Approach

OBJECTIVE: Systemic amyloid light chain (AL) amyloidosis is a rare plasma cell disease. However, the regulatory mechanisms of AL amyloidosis have not been thoroughly uncovered, identification of candidate genes and therapeutic agents for this disease is crucial to provide novel insights into explori...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Wenxiang, Wang, Honghua, Bai, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997413/
https://www.ncbi.nlm.nih.gov/pubmed/32099441
http://dx.doi.org/10.2147/PGPM.S228574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997413/
https://www.ncbi.nlm.nih.gov/pubmed/32099441
http://dx.doi.org/10.2147/PGPM.S228574

Ejemplares similares